
Sign up to save your podcasts
Or


Ella Al-Shamahi meets two women on the frontline in the fight against malaria.
Dr Ify Aniebo is from Nigeria, the country worst hit by malaria. She is an Associate professor with the African Centre of Excellence for Genomics of Infectious Diseases, where she works to improve the country's response to drug resistance and malarial transmission.
Dr Mehreen Datoo is a clinical lecturer in Infectious Diseases at the University of Oxford and she’s on the team that developed the R21/Matrix-M, the WHO approved vaccine that will be rolled out across Africa in 2024.
Produced by Alice Gioia, Emily Naylor and Jane Thurlow.
(Image: (L) Dr Mehreen Datoo, courtesy of Dr Mehreen Datoo. (R) Dr Ify Aniebo, courtesy Dr Ify Aniebo.)
By BBC World Service4.5
6969 ratings
Ella Al-Shamahi meets two women on the frontline in the fight against malaria.
Dr Ify Aniebo is from Nigeria, the country worst hit by malaria. She is an Associate professor with the African Centre of Excellence for Genomics of Infectious Diseases, where she works to improve the country's response to drug resistance and malarial transmission.
Dr Mehreen Datoo is a clinical lecturer in Infectious Diseases at the University of Oxford and she’s on the team that developed the R21/Matrix-M, the WHO approved vaccine that will be rolled out across Africa in 2024.
Produced by Alice Gioia, Emily Naylor and Jane Thurlow.
(Image: (L) Dr Mehreen Datoo, courtesy of Dr Mehreen Datoo. (R) Dr Ify Aniebo, courtesy Dr Ify Aniebo.)

7,683 Listeners

522 Listeners

1,065 Listeners

5,476 Listeners

1,805 Listeners

1,764 Listeners

1,057 Listeners

2,078 Listeners

499 Listeners

377 Listeners

394 Listeners

462 Listeners

314 Listeners

250 Listeners

3,208 Listeners

731 Listeners

1,037 Listeners

62 Listeners

106 Listeners

19 Listeners

47 Listeners

111 Listeners